Active — Not RecruitingNot Applicable

Gut Microbiota Profile and Its Impact on Immunity Status in COVID-19 Vaccinated Cohorts

Hong Kong215 participantsStarted 2021-05-14

Plain-language summary

This study aims to examine the association between gut microbiota composition and the magnitude and duration of immune response in subjects who have received different COVID-19 vaccines in Hong Kong and to identify the differences compared to those COVID-19 recovered subjects.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. aged ≥ 18 years old; and
✓. have documented to have no previous COVID-19 infection; and
✓. will receive any type of COVID-19 vaccines; and
✓. agree to hand in study samples (stool and blood); and
✓. agree to sign the informed consent
✓. aged ≥ 18 years old; and
✓. recovered from varying severity of COVID-19; and
✓. agree to hand in study samples (stool and blood); and

What they're measuring

To identify and compare the microbiome profile and immune response

Timeframe: 3 months

Trial details

NCT IDNCT04980560

SponsorChinese University of Hong Kong

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-06-17

View on ClinicalTrials.gov More COVID-19 Vaccination trials